We are live on ! Find out more
ADVM icon

Adverum Biotechnologies

Delisted

ADVM was delisted on the 8th of December, 2025.

76 hedge funds and large institutions have $153M invested in Adverum Biotechnologies in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

7.86% less ownership

Funds ownership: 67.69% → 59.83% (-7.9%)

17% less funds holding

Funds holding: 92 → 76 (-16)

28% less call options, than puts

Call options by funds: $1.57M | Put options by funds: $2.18M

43% less capital inflows, than outflows

Capital inflows: $18.3M | Capital outflows: $31.8M

76% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 25

Holders
76
Holders Change
-16
Holders Change %
-17.39%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
26
Reduced
26
Closed
25
Calls
$1.57​M
Puts
$2.18​M
Net Calls
-⁠$610​K
Net Calls Change
+$2.76​M

ADVM Hedge Fund Activity: Q4 2015 in Review

76 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2015, worth a combined $153M — up 6.5% from $144M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ADVM and 6 opened new positions — a net loss of 19 holders — while 26 trimmed existing stakes and 26 added.

The largest buyer was Numeric Investors, adding an estimated $3.97M. The largest seller was Redmile Group, cutting an estimated $6.36M.

  • 76 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2015, down from 92 in Q3 2015.
  • Funds reported $153M of Adverum Biotechnologies stock for Q4 2015, up 6.5% quarter-over-quarter.
  • 6 funds opened new Adverum Biotechnologies positions in Q4 2015 and 25 closed out, a net change of -19 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2015 was Numeric Investors, an estimated $3.97M added.
  • The largest Adverum Biotechnologies seller in Q4 2015 was Redmile Group, an estimated $6.36M sold.

Based on aggregated 13F filings for Q4 2015.